Sakamoto Yuya, Yano Takahisa, Hanada Yuki, Takeshita Aki, Inagaki Fumika, Masuda Satohiro, Matsunaga Naoya, Koyanagi Satoru, Ohdo Shigehiro
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; Department of Clinical Pharmacology and Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Department of Pharmacy, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Eur J Pharmacol. 2017 Apr 5;800:48-56. doi: 10.1016/j.ejphar.2017.02.025. Epub 2017 Feb 17.
Vancomycin (VCM) is a first-line antibiotic for serious infections caused by methicillin-resistant Staphylococcus aureus. However, nephrotoxicity is one of the most complaint in VCM therapy. We previously reported that VCM induced apoptosis in a porcine proximal tubular epithelial cell line (LLC-PK1), in which mitochondrial complex I may generate superoxide, leading to cell death. In the present study, VCM caused production of mitochondrial reactive oxygen species and peroxidation of the mitochondrial phospholipid cardiolipin that was reversed by administration of the mitochondrial uncoupler carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP). FCCP also significantly suppressed VCM-induced depolarization of the mitochondrial membrane and apoptosis. Moreover, the lipophilic antioxidant vitamin E and a mitochondria-targeted antioxidant, mitoTEMPO, also significantly suppressed VCM-induced depolarization of mitochondrial membrane and apoptosis, whereas vitamin C, n-acetyl cysteine, or glutathione did not provide significant protection. These findings suggest that peroxidation of the mitochondrial membrane cardiolipin mediated the VCM-induced production of intracellular reactive oxygen species and initiation of apoptosis in LLC-PK1 cells. Furthermore, regulation of mitochondrial function using a mitochondria-targeted antioxidant, such as mitoTEMPO, may constitute a potential strategy for mitigation of VCM-induced proximal tubular epithelial cell injury.
万古霉素(VCM)是治疗耐甲氧西林金黄色葡萄球菌引起的严重感染的一线抗生素。然而,肾毒性是VCM治疗中最常见的问题之一。我们之前报道过,VCM可诱导猪近端肾小管上皮细胞系(LLC-PK1)发生凋亡,其中线粒体复合体I可能产生超氧化物,导致细胞死亡。在本研究中,VCM导致线粒体活性氧生成以及线粒体磷脂心磷脂过氧化,而给予线粒体解偶联剂羰基氰化物-4-(三氟甲氧基)苯腙(FCCP)可逆转这一现象。FCCP还显著抑制了VCM诱导的线粒体膜去极化和凋亡。此外,亲脂性抗氧化剂维生素E和线粒体靶向抗氧化剂mitoTEMPO也显著抑制了VCM诱导的线粒体膜去极化和凋亡,而维生素C、N-乙酰半胱氨酸或谷胱甘肽则未提供显著保护作用。这些发现表明,线粒体膜心磷脂过氧化介导了VCM诱导的LLC-PK1细胞内活性氧生成及凋亡启动。此外,使用线粒体靶向抗氧化剂(如mitoTEMPO)调节线粒体功能可能构成减轻VCM诱导的近端肾小管上皮细胞损伤的潜在策略。